PRDX6 and cancer: The luciferase activity of cancer cells transfected with prdx6 promoter-Luc plasmid was over 5*104 RLU/mg proteins, and the treatment with thiacremonone caused the suppression of luciferase activity in cancer cells (Fig. 2A).